secwatch.observer — SEC 8-K summary
======================================

Issuer:     TALPHERA, INC. (TLPH)
CIK:        0001427925
Form:       8-K
Filed at:   2023-04-28T23:59:59+00:00
Accession:  0001437749-23-011613
Event type: regulatory
Sentiment:  negative
Materiality: 0.72
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

AcelRx receives Nasdaq deficiency notice for bid price below $1.00 per share
----------------------------------------------------------------------------

- Notice dated April 26, 2023; requires minimum $1.00 bid price for continued listing on Nasdaq Global Market.
- Company has 180 calendar days (until October 23, 2023) to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not cured, AcelRx may seek an additional 180-day period if it meets other Nasdaq Capital Market listing standards.
- Company states it will monitor bid price and evaluate options, including reverse stock split to cure deficiency.
- Nasdaq has not yet initiated delisting; listing remains unchanged at this time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427925/000143774923011613/0001437749-23-011613-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427925/000143774923011613/acrx20230426_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-011613

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer